311 related articles for article (PubMed ID: 25264129)
1. Carbapenem-resistant-only Pseudomonas aeruginosa infection in patients formerly infected by carbapenem-susceptible strains.
Tsai MH; Wu TL; Su LH; Lo WL; Chen CL; Liang YH; Chiu CH
Int J Antimicrob Agents; 2014 Dec; 44(6):541-5. PubMed ID: 25264129
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
Lee CH; Su TY; Ye JJ; Hsu PC; Kuo AJ; Chia JH; Lee MH
J Microbiol Immunol Infect; 2017 Oct; 50(5):677-683. PubMed ID: 26188977
[TBL] [Abstract][Full Text] [Related]
3. Reduced production of OprM may promote oprD mutations and lead to imipenem resistance in Pseudomonas aeruginosa carrying an oprD-group 1A allele.
Shu JC; Su LH; Chiu CH; Kuo AJ; Liu TP; Lee MH; Su IN; Wu TL
Microb Drug Resist; 2015 Apr; 21(2):149-57. PubMed ID: 25386722
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for and role of OprD protein in increasing minimal inhibitory concentrations of carbapenems in clinical isolates of Pseudomonas aeruginosa.
Hirabayashi A; Kato D; Tomita Y; Iguchi M; Yamada K; Kouyama Y; Morioka H; Tetsuka N; Yagi T
J Med Microbiol; 2017 Nov; 66(11):1562-1572. PubMed ID: 28984565
[TBL] [Abstract][Full Text] [Related]
5. Development of carbapenem resistance in Pseudomonas aeruginosa is associated with OprD polymorphisms, particularly the amino acid substitution at codon 170.
Shu JC; Kuo AJ; Su LH; Liu TP; Lee MH; Su IN; Wu TL
J Antimicrob Chemother; 2017 Sep; 72(9):2489-2495. PubMed ID: 28535274
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Pseudomonas aeruginosa isolates from patients with urinary tract infections during antibiotic therapy.
Horii T; Muramatsu H; Morita M; Maekawa M
Microb Drug Resist; 2003; 9(2):223-9. PubMed ID: 12820809
[TBL] [Abstract][Full Text] [Related]
7. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B
APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762
[TBL] [Abstract][Full Text] [Related]
8. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.
Kim CH; Kang HY; Kim BR; Jeon H; Lee YC; Lee SH; Lee JC
J Microbiol; 2016 Jan; 54(1):44-49. PubMed ID: 26727901
[TBL] [Abstract][Full Text] [Related]
9. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
Diene SM; L'homme T; Bellulo S; Stremler N; Dubus JC; Mely L; Leroy S; Degand N; Rolain JM
Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169
[TBL] [Abstract][Full Text] [Related]
10. Classification of OprD sequence and correlation with antimicrobial activity of carbapenem agents in Pseudomonas aeruginosa clinical isolates collected in Japan.
Sanbongi Y; Shimizu A; Suzuki T; Nagaso H; Ida T; Maebashi K; Gotoh N
Microbiol Immunol; 2009 Jul; 53(7):361-7. PubMed ID: 19563394
[TBL] [Abstract][Full Text] [Related]
11. Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study.
Ocampo-Sosa AA; Cabot G; Rodríguez C; Roman E; Tubau F; Macia MD; Moya B; Zamorano L; Suárez C; Peña C; Domínguez MA; Moncalián G; Oliver A; Martínez-Martínez L;
Antimicrob Agents Chemother; 2012 Apr; 56(4):1703-13. PubMed ID: 22290967
[TBL] [Abstract][Full Text] [Related]
12. Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallo-beta-lactamases, porin OprD and integrons.
Rojo-Bezares B; Estepa V; Cebollada R; de Toro M; Somalo S; Seral C; Castillo FJ; Torres C; Sáenz Y
Int J Med Microbiol; 2014 May; 304(3-4):405-14. PubMed ID: 24594145
[TBL] [Abstract][Full Text] [Related]
13. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
Lee JY; Ko KS
Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.
Hammami S; Ghozzi R; Burghoffer B; Arlet G; Redjeb S
Pathol Biol (Paris); 2009; 57(7-8):530-5. PubMed ID: 18977099
[TBL] [Abstract][Full Text] [Related]
15. Characterization of fluoroquinolone and carbapenem susceptibilities in clinical isolates of levofloxacin-resistant Pseudomonas aeruginosa.
Muramatsu H; Horii T; Takeshita A; Hashimoto H; Maekawa M
Chemotherapy; 2005 May; 51(2-3):70-5. PubMed ID: 15870499
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Carbapenem Resistance Mechanisms and Its Association with Pseudomonas aeruginosa Infections in the Northwest of Iran.
Akhi MT; Khalili Y; Ghotaslou R; Yousefi S; Kafil HS; Naghili B; Sheikhalizadeh V
Microb Drug Resist; 2018 Mar; 24(2):126-135. PubMed ID: 28654368
[TBL] [Abstract][Full Text] [Related]
17. Carbapenem resistance mechanism and risk factors of Pseudomonas aeruginosa clinical isolates from a University Hospital in Xi'an, China.
Zhang JF; Chen BL; Xin XY; Zhao HB; Wang HY; Song H; Xu ZK
Microb Drug Resist; 2009 Mar; 15(1):41-5. PubMed ID: 19226194
[TBL] [Abstract][Full Text] [Related]
18. Carbapenem nonsusceptibility with modified
Choudhury D; Talukdar AD; Choudhury MD; Maurya AP; Chanda DD; Chakravorty A; Bhattacharjee A
Indian J Med Microbiol; 2017; 35(1):137-139. PubMed ID: 28303836
[TBL] [Abstract][Full Text] [Related]
19. Characterization of carbapenem resistance mechanisms and integrons in Pseudomonas aeruginosa strains from blood samples in a French hospital.
Rojo-Bezares B; Cavalié L; Dubois D; Oswald E; Torres C; Sáenz Y
J Med Microbiol; 2016 Apr; 65(4):311-319. PubMed ID: 26838942
[TBL] [Abstract][Full Text] [Related]
20. [The roles of active efflux system overexpression and outer membrane protein OprD deficiency or loss in carbapenem resistance of Pseudomonas aeruginosa].
Yi MY; Wang PY; Huang HJ; Liu YC
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(7):457-62. PubMed ID: 16677571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
